Business Context and Reporting Period
This Form 8-K is filed by Greatbatch, Inc. (not Integer Holdings Corp as indicated in metadata) on January 13, 2014. The filing serves as a Regulation FD disclosure regarding an upcoming presentation by President and CEO Thomas J. Hook at the 32nd Annual J.P. Morgan Healthcare Conference on January 16, 2014.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references an attached presentation (Exhibit 99.1) that contains 2013 full-year estimated results and 2014 projected results, including non-GAAP financial measures.
Material Changes and Non-GAAP Adjustments
The filing outlines the methodology for "adjusted" non-GAAP amounts, which exclude specific items from GAAP results. These exclusions include:
- Acquisition-related charges and facility consolidation/optimization costs.
- Asset write-downs, disposition charges, and severance charges.
- Litigation charges/gains and non-cash interest expense impacts from convertible debt accounting changes.
- Unusual items, specific R&D expenditures (e.g., neuromodulation platform design verification testing), and gains/losses on investment sales.
- Tax charges related to the consolidation of the Swiss Orthopaedic facility.
Guidance, Outlook, and Risks
Outlook and Commentary: Management intends to discuss long-term growth strategy, profitability, and provide 2013 estimates and 2014 projections in the upcoming conference presentation.
Risks and Contingencies: The filing includes a cautionary statement regarding forward-looking statements. Key risks identified include:
- Dependence on a limited number of customers and customer ordering patterns.
- Product obsolescence, pricing pressure, and inability to market products.
- Reliance on third-party suppliers and challenges in cost reduction/plant consolidation.
- Intellectual property challenges, product liability claims, and regulatory changes.
- Global economic factors, including currency exchange rates.
- Integration risks associated with acquisitions.
Investor Verification Checklist
- Verify the specific 2013 estimated results and 2014 projections in the attached Exhibit 99.1 presentation.
- Review the reconciliation of non-GAAP measures to GAAP results provided in the presentation appendix.
- Confirm the company's ability to execute cost reduction and plant consolidation initiatives mentioned in the risk factors.
- Monitor the status of legal actions and the resolution of litigation charges referenced in the adjustments.
- Assess the impact of the Swiss Orthopaedic facility consolidation on future tax charges.